Archives

  • 2018-07
  • 2018-10
  • 2018-11
  • 2019-04
  • 2019-05
  • 2019-06
  • 2019-07
  • 2019-08
  • 2019-09
  • 2019-10
  • 2019-11
  • 2019-12
  • 2020-01
  • 2020-02
  • 2020-03
  • 2020-04
  • 2020-05
  • 2020-06
  • 2020-07
  • 2020-08
  • 2020-09
  • 2020-10
  • 2020-11
  • 2020-12
  • 2021-01
  • 2021-02
  • 2021-03
  • 2021-04
  • 2021-05
  • 2021-06
  • 2021-07
  • 2021-08
  • 2021-09
  • 2021-10
  • 2021-11
  • 2021-12
  • 2022-01
  • 2022-02
  • 2022-03
  • 2022-04
  • 2022-05
  • 2022-06
  • 2022-07
  • 2022-08
  • 2022-09
  • 2022-10
  • 2022-11
  • 2022-12
  • 2023-01
  • 2023-02
  • 2023-03
  • 2023-04
  • 2023-05
  • 2023-06
  • 2023-07
  • 2023-08
  • 2023-09
  • 2023-10
  • 2023-11
  • 2023-12
  • 2024-01
  • 2024-02
  • 2024-03
  • 2024-04
  • br Results and Discussion br Experimental Procedures br

    2018-10-20


    Results and Discussion
    Experimental Procedures
    Acknowledgments We would like to thank V. Makatounakis and G. Vretzos for technical assistance, as well as I. Stratidaki for her contribution in miRNA sequencing profiling by the Ion Torrent platform (IMBB). We also thank Prof. D. Kardasis and Prof. C. Stournara for providing cgrp antagonist and reagents used in these experiments. This work was funded by Thalis-MIS380247-MIREG (NSRF 2007–2013), Umbistem11SYN_10_668 and FP7-REGPOT-2012-CT2012-316223-InnovCrete.
    Introduction Overexpression of the four transcription factors, Oct4, Sox2, Klf4, and c-Myc (OSKM) is sufficient to reprogram somatic cells into induced pluripotent cells (iPSCs) (Jackson and Sridharan, 2013). The mechanism of reprogramming is incompletely elucidated due to the inefficiency of the process with about 5% of the cells reaching the iPSC state under standard serum or serum replacement culture conditions (Papp and Plath, 2013). While a variety of somatic cells have been used as a starting point for the reprogramming process (Hussein and Nagy, 2012), mechanistic studies have been largely limited to those using mouse embryonic fibroblasts (MEFs). Tracking reprogramming populations has delineated a series of events that take place in a timed manner such as the loss of somatic cell gene expression followed by mesenchymal to epithelial transition (MET) indicated primarily by the acquisition of the cell surface marker E-cadherin (Samavarchi-Tehrani et al., 2010; Li et al., 2010). This is followed by the gain of expression of pluripotency markers such as OCT4 and NANOG, by the appearance of stabilization markers such as DPPA4, and independence from exogenous reprogramming factor expression (Apostolou and Hochedlinger, 2013). Overlaid on these transitions, experiments on single cells have revealed an early stochastic phase of gene expression followed by a late hierarchical phase triggered by the activation of Sox2 (Buganim et al., 2012). Therefore, we were interested in determining if cells that expressed endogenous SOX2 followed the same pathway as MEFs and focused on reprogramming both adult stem cells (neural stem cells [NSCs]) and differentiated cells (astrocytes) from the neural lineage. Both human and mouse NSCs can be reprogrammed with the omission of exogenous Sox2 in the reprogramming cocktail (Kim et al., 2008), and can even be reprogrammed with Oct4 alone (Kim et al., 2009). NSCs can also be more readily reprogrammed to intermediate stages, called partially reprogrammed cells, than MEFs (Silva et al., 2008). Remarkably, we found that upon induction of reprograming, in both NSCs and astrocytes, NANOG expression preceded or was concomitant with E-cadherin expression and the expression of SSEA1, an intermediate marker of pluripotency. Abrogation of E-cadherin expression through shRNA-mediated knockdown reduces reprogramming efficiency from MEFs and compromises the quality of iPSCs obtained (Chen et al., 2010), while MEFs lacking E-cadherin cannot form Nanog+ colonies (Redmer et al., 2011). E-cadherin can also replace Oct4 in the reprogramming factor cocktail (Redmer et al., 2011). Truncations of E-cadherin in MEF reprogramming revealed the necessity of the extracellular domain (Chen et al., 2010). Interestingly, in the absence of E-cadherin in embryonic stem cells (ESCs), N-cadherin is able to functionally replace E-cadherin to maintain pluripotency (Hawkins et al., 2012). We found that Nanog+ colonies from NSC reprogramming cultures can have N-cadherin, E-cadherin, or neither cadherin. However, colonies that expressed stabilization markers (Golipour et al., 2012), such as Dppa4, and that were transgene independent always co-expressed NANOG and E-cadherin. Gene expression analysis of populations sorted for expressing NANOG alone (N+) or NANOG and E-cadherin (N+E+) revealed that the N+E+ population expressed higher levels of cell cycle genes suggesting a greater propensity to expand. Finally, enhancing MET by inhibiting the histone methyltransferase, DOT1l (Onder et al., 2012) increased both N+ and N+E+ colony numbers.